Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Juni 2019

Planlagt Fastgjort Låst Flyttet Genmab
2.2k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • BulderB Offline
    BulderB Offline
    Bulder
    wrote on sidst redigeret af
    #137

    Mon det var fordi Winkel lå i forhandlinger om en M&A, som nu er gået i vasken?;-)

    1 Reply Last reply
    0
    • S Offline
      S Offline
      Sukkeralf
      wrote on sidst redigeret af
      #138

      Jeg synes det er lidt spøjst - bl.a. er både Morgan og Jefferies book-running managers for Genmab ved Nasdaq noteringen.

      1 Reply Last reply
      0
      • S Offline
        S Offline
        Sukkeralf
        wrote on sidst redigeret af
        #139

        Men det kan være de lige skal forkæles lidt før vi andre bliver involveret

        1 Reply Last reply
        0
        • S Offline
          S Offline
          Sukkeralf
          wrote on sidst redigeret af
          #140

          https://endpts.com/asco19-amgen-shows-off-their-latest-bcma-bite-update-with-plans-to-hustle-ahead-as-rivals-jostle-for-position/

          1 Reply Last reply
          0
          • S Offline
            S Offline
            Sukkeralf
            wrote on sidst redigeret af
            #141

            https://endpts.com/asco19-sanofi-sets-the-stage-for-a-late-arrival-of-their-multiple-myeloma-drug-isatuximab-with-jj-and-genmab-laying-in-wait/

            1 Reply Last reply
            0
            • S Offline
              S Offline
              Sukkeralf
              wrote on sidst redigeret af
              #142

              ....And they are acutely aware of the threat Sanofi poses, with Genmab singling out isatuximab as a top threat in their newly filed IPO.

              1 Reply Last reply
              0
              • J Offline
                J Offline
                Jazzz
                wrote on sidst redigeret af
                #143

                Priority review.. “positiv men kursneutral”.. Maia, som jeg forstår det, er også positiv men stort set kursneutral..Er der nogen der kan forklare, hvad en positiv og kurs stigende nyhed kunne være? Venter vi kun på at salget stiger mod de 10 mia som planlagt, SC og så pipeline? Eller er der andre og måske kortsigtede kurstriggere?

                1 Reply Last reply
                0
                • StockBullS Offline
                  StockBullS Offline
                  StockBull
                  wrote on sidst redigeret af
                  #144

                  Jo mere "sikker" Peaksales på 10mia bliver jo hurtigere vil kursen stige. MAIA er et skridt på den vej og derfor vil kursen også stige i.f.m godkendelse. Hvis det var 100% sikkers peaksales vil nå 10 mia ville kursen jo allerede nu ligge over 2500kr

                  1 Reply Last reply
                  0
                  • nohopeN Offline
                    nohopeN Offline
                    nohope
                    wrote on sidst redigeret af
                    #145

                    Sålænge de brænder hver en krone af deres indtægter og kræver yderligere penge ind, så er kurs 2500 langt væk.

                    1 Reply Last reply
                    0
                    • SolsenS Offline
                      SolsenS Offline
                      Solsen
                      wrote on sidst redigeret af
                      #146

                      En ting er sikkert. De kan ikke lave en IPO med kendskab til kommende dårligdomme såsom MAIA fail eller SC fail etc
                      .

                      1 Reply Last reply
                      0
                      • J Offline
                        J Offline
                        JKY_VH
                        wrote on sidst redigeret af
                        #147

                        Jazz her er Novods Key upside risks: "A restart of the solid tumour trials after review of the data;
                        faster-than-expected approval of MAIA 1L MM label expansion; failure of
                        competing CAR-T drugs in MM; strong early-stage pipeline data and potential
                        M&A with Genmab as a target."

                        1 Reply Last reply
                        0
                        • SolsenS Offline
                          SolsenS Offline
                          Solsen
                          wrote on sidst redigeret af
                          #148

                          Tror at IPOen kommer efter en 50/50 partner meddelelse for at sikre finansieringen af udviklingen.

                          1 Reply Last reply
                          0
                          • J Offline
                            J Offline
                            JKY_VH
                            wrote on sidst redigeret af
                            #149

                            Lad os håbe det

                            1 Reply Last reply
                            0
                            • J Offline
                              J Offline
                              Jazzz
                              wrote on sidst redigeret af
                              #150

                              Ok. Tak JKY.. klart nok.

                              1 Reply Last reply
                              0
                              • Legolas23L Offline
                                Legolas23L Offline
                                Legolas23
                                wrote on sidst redigeret af
                                #151

                                Så sælg dog 🙂

                                1 Reply Last reply
                                0
                                • Legolas23L Offline
                                  Legolas23L Offline
                                  Legolas23
                                  wrote on sidst redigeret af
                                  #152

                                  Brok, brok og brok.

                                  1 Reply Last reply
                                  0
                                  • J Offline
                                    J Offline
                                    JKY_VH
                                    wrote on sidst redigeret af
                                    #153

                                    Du må spille det fede nummer med BTO igen Pensionisten;-)

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #154

                                      my thoughts on timing are slightly different; ASCO is one of the biggest media and investor spectacles in the bio / pharma world; a good time to create media attention and promote oneself. In addition to the upcoming investor conferences.

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #155

                                        i don't like the fact that they are somewhat vague about the purpose either, but there may be a reason for that, so I'll just have to wait and see what that is...

                                        1 Reply Last reply
                                        0
                                        • P Offline
                                          P Offline
                                          peter12
                                          wrote on sidst redigeret af
                                          #156

                                          De er da utrolig detaljerede om formålet ?

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger